stockrowIntuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
Follow ISRG
Alert me
Intuitive Surgical, Inc. (ISRG) Revenue
Intuitive Surgical, Inc.'s revenue for fiscal 2025 was $10.1B, up 20.5% from $8.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $11.6B. Over the past ten years it has ranged from $2.4B (fiscal 2015) to $10.1B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 5 consecutive fiscal years. Intuitive Surgical, Inc. ranks 4th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $10.1B | 20.51% |
| FY2024 | $8.4B | 17.24% |
| FY2023 | $7.1B | 14.49% |
| FY2022 | $6.2B | 8.97% |
| FY2021 | $5.7B | 31.01% |
| FY2020 | $4.4B | (2.68%) |
| FY2019 | $4.5B | 20.25% |
| FY2018 | $3.7B | 18.67% |
| FY2017 | $3.1B | 15.95% |
| FY2016 | $2.7B | 13.51% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $3.0B | 5.41% |
| Jun 2026 | $2.9B | 4.39% |
| Mar 2026 | $2.8B | (3.33%) |
| Dec 2025 | $2.9B | 14.41% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| MDLN Medline Inc. compare | $30.7B |
| BDX Becton, Dickinson and Company compare | $20.8B |
| BAX Baxter International Inc. compare | $11.6B |
| ISRG Intuitive Surgical, Inc. | $11.6B |
| ALC Alcon compare | $10.9B |
| SOLV Solventum Corporation compare | $8.2B |
| RMD ResMed Inc. compare | $5.7B |
| COO The Cooper Companies, Inc. compare | $4.2B |
| WST West Pharmaceutical Services, Inc. compare | $3.4B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ISRG
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement